1. Treating Myocardial Infarction in the Post-GUSTO Era

   • Daniel Mark

   Current Opinion 25 November 2012 Pages: 473 - 477

2. The Impact of User Charges on the Consumption of Drugs

   • Ulf-G. Gerdtham
   • Magnus Johannesson

   Leading Article 25 November 2012 Pages: 478 - 483

3. Is There Scope for Improving the Cost-Effective Prescribing of Nonsteroidal Anti-Inflammatory Drugs?

   • Karen Bloor
   • Alan Maynard

   Review Article 25 November 2012 Pages: 484 - 496

4. Clinical and Cost Considerations in the Pharmacotherapy of Vulvovaginal Candidiasis

   • Ignatius W. Fong

   Review Article 25 November 2012 Pages: 497 - 505

5. Statistical Analysis in Pharmacoeconomic Studies

   • Douglas Coyle

   Review Article 25 November 2012 Pages: 506 - 516

6. A Cost Analysis of Alprostadil in Liver Transplantation

   • Dean G. Smith
   • Keith S. Henley
   • I. Douglas McLaren

   Original Research Article 25 November 2012 Pages: 517 - 524

7. Estimating the Cost Effectiveness of Atovaquone versus Intravenous Pentamidine in the Treatment of Mild-to-Moderate Pneumocystis carinii Pneumonia

   • Gary A. Zarkin
   • Mohan V. Bala
   • Michael N. Dohn

   Original Research Article 25 November 2012 Pages: 525 - 534

8. Canadian Guidelines for Economic Evaluation of Pharmaceuticals

   • George W. Torrance
   • David Blaker
   • Theresa Firestone

   Special Article 25 November 2012 Pages: 535 - 559

9. Glossary

   News 25 November 2012 Pages: 564 - 567